Von Willebrand factor, ADAMTS13, and coronary microvascular obstruction: Beautiful hypotheses, ugly facts

Cardiovascular Research

Volumn 111, Issue 3, 2016, Pages 169-171

  De Caterina, Raffaele ^a   Madonna, Rosalinda ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAMTS13 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; BRAIN ISCHEMIA; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; MICROVASCULATURE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; HEART INFARCTION;

ADAMTS13 PROTEIN; HUMANS; MYOCARDIAL INFARCTION; VON WILLEBRAND FACTOR;

EID: 84983001888     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw165     Document Type: Editorial

References (31)

1. Huxley T. Biogenesis and abiogenesis. In: Presidential Address at the British Association, Later Published in Collected Essays, Vol 8. 1870, p. 229.
2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362: 2155-2165.
3. Gersh BJ, StoneGW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 2005;293:979-986.
4. Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, Gurm HS. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 2013;369:901-909.
5. Niccoli G, Scalone G, Lerman A, Crea F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J 2016;37:1024-1033.
6. Herrmann J, Lerman A. The endothelium: dysfunction and beyond. J Nucl Cardiol 2001; 8:197-206.
7. Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J 2007; 28:788-797.
8. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356: 830-840.
9. Bekkers SC, SmuldersMW, Passos VL, Leiner T, Waltenberger J, Gorgels AP, Schalla S. Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging. Eur Radiol 2010;20:2572-2578.
10. Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van Royen N. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J 2013;34:2346-2353.
11. Betgem RP, deWaard GA, Nijveldt R, Beek AM, Escaned J, van Royen N. Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol 2015;12:156-167.
12. Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, ChopekMW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986;25:3171-3184.
13. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982;95:355-360.
14. Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost 1999; 82:576-584.
15. Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006;4:1186-1193.
16. Crawley JT, de Groot R, Xiang Y, Luken BM, Lane DA. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood 2011;118: 3212-3221.
17. Turner NA, Nolasco L, Ruggeri ZM, Moake JL. Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. Blood 2009;114:5102-5111.
18. Zheng XL. Structure-function and regulation of ADAMTS-13 protease. J Thromb Haemost 2013;11(Suppl 1):11-23.
19. van Schie MC, van Loon JE, de Maat MP, Leebeek FW. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review. J Thromb Haemost 2011;9:899-908.
20. Matsukawa M, Kaikita K, Soejima K, Fuchigami S, Nakamura Y, Honda T, Tsujita K, Nagayoshi Y, Kojima S, Shimomura H, Sugiyama S, Fujimoto K, Yoshimura M, Nakagaki T, Ogawa H. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol 2007; 100:758-763.
21. Rutten B, Maseri A, Cianflone D, Laricchia A, Cristell NA, Durante A, Spartera M, Ancona F, Limite L, Hu D, Li H, Uren NG, de Groot PG, Mannucci PM, Roest M. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study. Eur Heart J Acute Cardiovasc Care 2015;4:64-74.
22. Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H. Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost 2006;4:2490-2493.
23. Fujioka M, Nakano T, Hayakawa K, Irie K, Akitake Y, Sakamoto Y, Mishima K, Muroi C, Yonekawa Y, Banno F, Kokame K, Miyata T, Nishio K, Okuchi K, Iwasaki K, Fujiwara M, Siesjo BK. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. Neurol Sci 2012;33:1107-1115.
24. Jin SY, Tohyama J, Bauer RC, Cao NN, Rader DJ, Zheng XL. Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model. Arterioscler Thromb Vasc Biol 2012;32:1817-1823.
25. Gandhi C, Motto DG, Jensen M, Lentz SR, Chauhan AK. ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice. Blood 2012;120:5224-5230.
26. Zhao BQ, Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M, Scheiflinger F, Wagner DD. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 2009;114:3329-3334.
27. Eerenberg E, Teunissen P, van den Born B, Meijers J, Hollander M, Jansen M, Tijssen R, Beliën J, van de Ven P, Aly M, Kamp O, Niessen H, Kamphuisen P, Levi M, van Royen N. The role of ADAMTS13 in acute myocardial infarction: 1 cause or consequence? Cardiovasc Res 2016;111:194-203.
28. Matosin N, Frank E, Engel M, Lum JS, Newell KA. Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture. Dis Model Mech 2014;7:171-173.
29. De Caterina R, Griffioen AW, Porreca F. Fraud in biomedical research-the role of journal Editors. Vascul Pharmacol 2011;55:119-120.
30. Fanelli D. Do pressures to publish increase scientists' bias? An empirical support from US States Data. PLoS One 2010;5:e10271.
31. Fanelli D. Positive results increase down the hierarchy of the sciences. PLoS One 2010; 5:e10068.